The immune response in glaucoma: a perspective on the roles of oxidative stress
about
Current perspective of neuroprotection and glaucomaFrom mechanosensitivity to inflammatory responses: new players in the pathology of glaucomaThioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signalingROS detoxification and proinflammatory cytokines are linked by p38 MAPK signaling in a model of mature astrocyte activationAn approach to predict the risk of glaucoma development by integrating different attribute data.A decade of proteomics studies of glaucomatous neurodegeneration.Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective.Retinal stem cells transplantation combined with copolymer-1 immunization reduces interferon-gamma levels in an experimental model of glaucoma.Novel role for the innate immune receptor Toll-like receptor 4 (TLR4) in the regulation of the Wnt signaling pathway and photoreceptor apoptosisThe association of glutathione S-transferase GSTT1 and GSTM1 gene polymorphism with pseudoexfoliative glaucoma in a Pakistani populationSteady-state levels of retinal 24S-hydroxycholesterol are maintained by glial cells intervention after elevation of intraocular pressure in the rat.Status of systemic oxidative stresses in patients with primary open-angle glaucoma and pseudoexfoliation syndromeRetinal transcriptome profiling at transcription start sites: a cap analysis of gene expression early after axonal injury.Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina.Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma.Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina.Proteomics Analysis of Molecular Risk Factors in the Ocular Hypertensive Human RetinaAn astrocyte-specific proteomic approach to inflammatory responses in experimental rat glaucomaA mouse ocular explant model that enables the study of living optic nerve head events after acute and chronic intraocular pressure elevation: Focusing on retinal ganglion cell axons and mitochondria.Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma.Immune regulation toward immunomodulation for neuroprotection in glaucoma.Molecular biomarkers in glaucomaA proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration.Antioxidant Treatment Limits Neuroinflammation in Experimental Glaucoma.Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for GlaucomaGlioprotection of Retinal Astrocytes After Intravitreal Administration of Memantine in the Mouse Optic Nerve Crush ModelThe association between serum uric acid and glaucoma severity in primary angle closure glaucoma: a retrospective case-control study.Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential.Oxidative stress and potential applications of free radical scavengers in glaucoma.Metallothioneins (MTs) in the human eye: a perspective article on the zinc-MT redox cycle.The complex role of neuroinflammation in glaucoma.Application of multiplex immunoassay technology to investigations of ocular disease.Genetic and Biochemical Biomarkers in Canine Glaucoma.The D₁ dopamine receptor agonist, SKF83959, attenuates hydrogen peroxide-induced injury in RGC-5 cells involving the extracellular signal-regulated kinase/p38 pathways.The role and therapeutic potential of melatonin in age-related ocular diseases.Proteomics analyses of human optic nerve head astrocytes following biomechanical strain.Early remodelling of the extracellular matrix proteins tenascin-C and phosphacan in retina and optic nerve of an experimental autoimmune glaucoma model.Good news-bad news: the Yin and Yang of immune privilege in the eye.Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection.Reactive oxygen species, oxidative stress, glaucoma and hyperbaric oxygen therapy.
P2860
Q26774852-9D2DFA71-ADB2-4D6E-8A7E-8712291AB812Q26864408-17472647-F066-48D3-B320-8302EB2EF518Q28389739-3BA33798-D1DE-42B3-85BE-201EF337EAAAQ28537957-05EA877A-688D-421F-950D-37D25656D631Q30662499-A03B93ED-8ED7-4D0D-B553-DCB31B57B3F2Q33570764-80799326-FB4C-41D7-9B8F-D3061C0B4813Q33719355-D6B7268A-CE21-46FB-A773-5DCDE9F495EBQ34254620-642BDE62-0039-42AF-8739-2ECEA3A61A11Q34277319-ED989912-02AE-4ACD-8164-4791ECE44BE0Q34364056-DFFFCCA9-9975-4B67-9164-29B1F3721ECBQ34418826-6ABB7248-DE30-4065-94D7-0EB3EBB39C06Q34493810-5FF3B873-32F9-4BD6-9ED6-44BAA7C9330CQ34582221-B11875CB-1139-47B2-A769-83079E501EA8Q34603641-0B497AD1-543D-4CF6-9940-7272162931DBQ35157723-59BAB461-495F-4A54-8720-F73882781BF2Q35524470-8C6341B0-0F0F-4A18-9250-68B54F001B79Q36050618-C3F0EE22-95A4-489C-973C-1253693069E9Q36082780-0ED58DAD-5E20-426D-8F4E-88D66CDF7E4AQ36348165-26CD6FEB-6F9B-4FA0-999F-02F77E9D6583Q36467223-2D151991-F8EB-4A52-9340-D1BD8E814F6AQ36487609-87E1FB08-3189-4BBE-B6A0-5DA136D5F45BQ36530573-5DED631C-557A-4202-B144-09E4000E62AEQ36828359-D6F096A9-6416-4C1B-8750-AA68A89C3BABQ36867011-47E316D5-091C-4D82-A027-41C7E7ABC2AAQ37015439-BE87CDFD-0A4E-4994-9435-33C62154C6FBQ37702027-C6ECAD4E-53A5-468B-954F-55CA99F7DD76Q37709378-4482609B-DE06-4DA9-A5BB-F649BF72802BQ38031910-20EC1ED9-F011-409D-9F22-4F0BF7656405Q38088831-13D26F81-2962-4808-9916-1E28B81971D1Q38178092-C0A1624D-0480-4CD8-83BA-21B09A0F2FAEQ38226119-02EF4C6C-06F2-4957-87F8-60953398BCC8Q38941639-76729E9F-2A06-4FE5-836B-1F5A3FC6A78DQ38966980-B869A7E0-59B2-40EF-AC83-1DB9323E3DA4Q39227370-485425A2-3562-42B6-9EA1-47F9D5E7A08CQ39402838-61271AF0-F5A5-407C-8309-D96583AAD447Q41044103-B880D82C-FF54-4CA2-B265-3155A6213330Q41592935-2991E4D2-6013-415F-AB8F-7F048938F638Q41780299-4BBD45F8-E48E-48B7-AFE2-0D2C9041E793Q42328273-62A8B62A-4EFB-4D1D-8B72-E8C1FD4F38EFQ46328207-2FC5FFA0-6094-4788-847C-3E7F4573A4E7
P2860
The immune response in glaucoma: a perspective on the roles of oxidative stress
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
The immune response in glaucoma: a perspective on the roles of oxidative stress
@ast
The immune response in glaucoma: a perspective on the roles of oxidative stress
@en
The immune response in glaucoma: a perspective on the roles of oxidative stress
@nl
type
label
The immune response in glaucoma: a perspective on the roles of oxidative stress
@ast
The immune response in glaucoma: a perspective on the roles of oxidative stress
@en
The immune response in glaucoma: a perspective on the roles of oxidative stress
@nl
prefLabel
The immune response in glaucoma: a perspective on the roles of oxidative stress
@ast
The immune response in glaucoma: a perspective on the roles of oxidative stress
@en
The immune response in glaucoma: a perspective on the roles of oxidative stress
@nl
P2860
P1476
The immune response in glaucoma: a perspective on the roles of oxidative stress
@en
P2093
Gülgün Tezel
P2860
P304
P356
10.1016/J.EXER.2010.07.009
P577
2010-08-13T00:00:00Z